News room
Technophage attends 13th Annual World ADC 2023
Technophage's Head of Neurosciences Raquel Ferreira is currently in London at the 13th Annual World ADC 2023, learning with the best, about the...
Technophage patent portfolio
TechnoPhage is currently working on several projects in different therapeutic areas, such as infection, ophthalmology, or neuroscience, among which...
Technophage is hiring a Junior Clinical Trial Manager
TechnoPhage is currently looking for a Junior Clinical Trial Manager to join our clinical research team. The candidate should have an academic...
TechnoPhage announces completion of innovative clinical trial with bacteriophage cocktail indicated for the treatment of diabetic foot infections
TechnoPhage is proud to announce that the Phase I/IIa Clinical Trial of TP-102, a novel bacteriophage cocktail developed for the treatment of...
TechnoPhage Announces Application of TP-102 Product in Two Compassionate Use Cases
TechnoPhage announced that it has provided TP-102, developed for the treatment of infected diabetic foot ulcers, for two compassionate use cases,...